←
samyounglab823 posts
samyounglab avatar

samyounglab

@SamYoungLab

Deciphering cellular and molecular mechanisms of synaptic function and impact on neuronal circuit output. Viral vector development and CNS gene therapy.

◷ Joined December 2018▧ 95 Photos and videos
Lu-Yang Wang avatar
⟳ samyounglab retweeted
Lu-Yang Wang@SynapticTweeter·10 Jul 2024

Delighted to share our new Nature paper: rdcu.be/dNlMQ This works shows a surprising off-target effect of glutamate on another cell death channel, acid sensing ion channels (ASICs). It turns out that glutamate directly binds to ASICs as a positive allosteric modulator

samyounglab avatar
samyounglab@SamYoungLab·10 Jul 2024

Amazing findings !! Congrats you and the team

Delighted to share our new Nature paper: rdcu.be/dNlMQ This works shows a surprising off-target effect of glutamate on another cell death channel, acid sensing ion channels (ASICs). It turns out that glutamate directly binds to ASICs as a positive allosteric modulator

Matt Hill avatar
⟳ samyounglab retweeted
Matt Hill@canna_brain·8 Jul 2024

So for those of you interested in what it was that I took issue with in Hubermans first cannabis podcast, this is the Coles notes of the errors/inaccuracies that I noted. A lot of this is covered in the new episode, but some wont make it through and for others this is the TLDR

New Huberman Lab podcast out now: CANNABIS: EFFECTS ON HEALTH & RISKS w/guest @canna_brain •THC, CBD Biology •Cannabis & Psychosis •Is THC addictive? •Are Strain Differences Real or Placebo? •Appetite, Hormones •Dosage Control: Inhaled vs Edible hubermanlab.com/episode/dr-m…

samyounglab avatar
samyounglab@SamYoungLab·9 Jul 2024

Love cellular and molecular neuro. We are hiring a staff scientist interested in building framework of molecular principles for accurate sound information encoding and contribution to auditory deficits. unc.peopleadmin.com/hr/posti… Must have background in patch clamp DM or email

samyounglab avatar
samyounglab@SamYoungLab·1 Jul 2024

Big news. We are moving. I have officially started as the Director of the Gene Therapy Center, and as a Professor of Pediatrics and Professor of Pharmacology at UNC-Chapel Hill. I am returning “home” to lead the Center where I earned my PhD.

samyounglab avatar
samyounglab@SamYoungLab·1 Apr 2024

Finally, I want to thank Dr. Emre Kul, Uchechi Okorafor @MissSafie and the rest of the team for taking on this immense challenge to solve a fundamental problem in the gene therapy field.

samyounglab avatar
samyounglab@SamYoungLab·1 Apr 2024

Since Ad vector transduction properties are dependent on their capsid proteins, these chimeric 1st generation Ad vectors open new avenues for high capacity helper-dependent adenovirus (HdAd) gene therapy approaches for cerebellar disorders and multiple neurological disorders.

samyounglab avatar
samyounglab@SamYoungLab·1 Apr 2024

Using a “humanized” hCD46 mouse model, we demonstrate these Ad vectors transduce cerebellar cell-types, including Purkinje cells, that are refractory to Ad5 transduction.

samyounglab avatar
samyounglab@SamYoungLab·1 Apr 2024

Therefore, to overcome the current limitations of Ad vectors to treat CNS disorders, we created chimeric 1st generation Ad vectors that utilize the hCD46 receptor.

samyounglab avatar
samyounglab@SamYoungLab·1 Apr 2024

However, these Ad5 vectors are unable to transduce many neuronal cell types that are dysfunctional in many CNS disorders. The human CD46 (hCD46) receptor is widely expressed throughout the human CNS and is the primary attachment receptor for many Ad serotypes.

samyounglab avatar
samyounglab@SamYoungLab·1 Apr 2024

Adenoviral vectors (Ad) have tremendous potential for CNS gene therapy approaches. Currently, the most common vectors utilize the Group C Ad5 serotype capsid proteins, which rely on the Coxsackievirus-Adenovirus receptor (CAR) to infect cells.

samyounglab avatar
samyounglab@SamYoungLab·1 Apr 2024

Viral vector gene therapy has immense promise for treating central nervous system (CNS) disorders. Although adeno-associated virus vectors (AAV) have had success, their small packaging capacity limit their utility to treat the root cause of many CNS disorders.

samyounglab avatar
samyounglab@SamYoungLab·1 Apr 2024

For ~25 years Ad vectors had little to no ability to transduce Purkinje cells, until now! Excited to announce our paper in MTMCD @MolTherapy on the development of Ad vectors that transduce Purkinje cells in a humanized mouse model shorturl.at/wyBW5

Post attachment
samyounglab avatar
samyounglab@SamYoungLab·16 Jan 2024

We are cranking away to get at this code that determine tpresynaptic Cav2 subtype specificity as it is a the keystone that determines how neuronal circuits transmit information in health and disease